While the FDA reviews whether there is a shortage of the tirzepatide, it will still allow compounding pharmacies and facilities to keep providing the drugs, according to Reuters.
Start with our getting started with peptides guide, or review the peptide safety guide
These observations from brand content are consistent with what structural biology and the rapid-weight-loss research literature describe about lean tissue loss during aggressive caloric restriction
What matters is who is in the space, what they are building, and what their estates actually cover
Adjustments to dosage or timing of the medication may be necessary to alleviate these gastrointestinal issues
The firms own SOP states that OOS results must be immediately reported to Quality and the pharmacist-in-charge, and that investigation, root cause analysis, recall, and customer notification procedures shall be followed when applicable. The FDA pointedly notes that the when applicable language effectively makes investigation and notification optional rather than mandatory